Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2013 by Retina Macula Institute.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Allergan
Information provided by (Responsible Party):
Retina Macula Institute
ClinicalTrials.gov Identifier:
NCT01449682
First received: October 6, 2011
Last updated: January 13, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2013
  Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)